As can be seen, the expression level of RIG-G mRNA was extremely low at the onset of APL, but significantly increased after ATRA-treatment (n = 7; p= 0.001), and it was lower again in 3 recurrence patients (p = 0.017; Figure 4A). The gene discussed is IFIT3; the disease is acute promyelocytic leukemia.